Recent News
Cholesterol Drugs Called Statins Could Help Extend Mesothelioma Sufferers’ Lives
A group of drugs called statins used for controlling cholesterol are showing that they can help mesothelioma patients taking PD-1 inhibitors survive longer. Researchers in Italy and the Netherlands found[…]
The ONCOS-102 Vaccine is Still Showing Promising Results
The ONCOS-102 immunotherapy vaccine is still showing promising results. Information from November shows when patients take the treatment with chemotherapy, it helped patients survive a minimum of 18.2 months. The[…]
Peritoneal Mesothelioma Surgery with More organ Removal Can Help Survival
Mesothelioma surgery that removes more of an organ has been found to extend the survival of patients. It also did not increase the chance of severe complications nor did it[…]
Mesothelioma Symptom Management Tool Links Doctors and Patients with a Smartphone
A study looking at a system that connects doctors and patients with a smartphone is showing that it could make the management of mesothelioma symptoms easier. Mesothelioma is a fast[…]
The Herpes Virus is Being Tested as a Mesothelioma Treatment
An altered herpes virus is being tested in mesothelioma patients, and the results show that it can stabilize the growth of mesothelioma tumors. Half of the patients given the virus[…]
Research is Showing That Mesothelioma Patients Could Benefit from Vitamin D3
Vitamin D3 could potentially be used to slow down mesothelioma. There are promising results coming from a study in Italy studying the possibilities of Vitamin D3 on mesothelioma cells. Results[…]
Reducing UHRF1 Could Lengthen Mesothelioma Sufferers’ Lives
The protein UHRF1 could help people survive pleural mesothelioma. Research from the National Cancer Institute found this protein. The protein is encoded by the gene with the same name. Researchers[…]
A New T-Cell Treatment is Being Tested on Mesothelioma Patients
A new clinical trial at the Memorial Sloan Kettering Cancer Center is recruiting patients for a pleural mesothelioma study. The treatment involves T-cell therapy and is a very promising treatment[…]
Opdivo and Yervoy Have Been Fully Approved for Treating Mesothelioma
A new treatment has been approved for mesothelioma by the Food and Drug Administration (FDA). The treatment uses a combination of Opdivo (nivolumab) and Yervoy (ipilimumab), which are immunotherapy drugs[…]
New Immuno-Radiology Treatment Being Tested on Mesothelioma
Mesothelioma is a cancer with a bad prognosis that is primarily caused by asbestos exposure. There is no cure for mesothelioma, so people diagnosed with the disease do not have[…]
Skip to content